AegirBio AB(SE:SUBGEN)
kr 0.03-0.01 (-15.63%)
SE:SUBGEN
AegirBio AB Revenue
kr 0.03
At close:-0.01 (-15.63%)
Want to see SE:SUBGEN full AI Analyst Report?
AegirBio AB (SUBGEN) Revenue
1 Followers
AegirBio AB Revenue
AegirBio AB had a revenue of 61.96M in the quarter ending Jun 30, 2026, with 32.62%. This bring the company's revenue in the last twelve months to 215.49M, Increased 90.74%. In the fiscal year ending Mar 31, 2026, AegirBio AB had annual revenue of 204.39M with 0.31% growth.
- Revenue (ttm)
- 215.49M
- Revenue Growth
- ―
- P/S Ratio
- 0.35
- Revenue/Employee
- SEK 814,287
- Employees
- 251
- Market Cap
- SEK 71.52M
Revenue Chart
AegirBio AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 204.39M | 630.00K | 0.31% |
| Dec 31, 2024 | 203.76M | 203.66M | 221373.91% |
| Dec 31, 2023 | 92.00K | -1.61M | -94.61% |
| Dec 31, 2022 | 1.71M | -11.58M | -87.16% |
| Dec 31, 2021 | 13.28M | 13.28M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.